Affordable Access

Publisher Website

Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat

Authors
Journal
Brain Research
0006-8993
Publisher
Elsevier
Publication Date
Volume
435
Identifiers
DOI: 10.1016/0006-8993(87)91597-6
Keywords
  • Bay K8644
  • Nicardipine
  • Dihydropyridine
  • Hippocampus
  • Spontaneously Hypertensive Rat
  • Acetylcholine

Abstract

Abstract Intracerebroventricular (i.c.v.) injection of the 1,4-dihydropyridine (DHP) calcium channel agonist, Bay K8644 (30 μg/kg) increased mean blood pressure and the K +-evoked release of [ 3H]acetylcholine ([ 3H]ACh) from hippocampal slices in spontaneously hypertensive rats (SHR). The Bay K8644-induced hypertension was inhibited by a pretreatment with methylatropine (80 μg/kg, i.c.v.). In SHR, nicardipine, a DHP calcium channel antagonist, reduced mean blood pressure when i.c.v. injected (10 μg/kg). The nicardipine-induced hypotension was reduced by a pretreatment with hemicholinium-3 (20 μg, i.c.v.). Nicardipine (1 μM) did not modify, in SHR, the K +-evoked release of [ 3H]ACh, but inhibited the Bay K8644-induced increase in the ACh release. In normotensive rats, neither Bay K8644 nor nicardipine modify blood pressure, when centrally injected, or the stimulated release of [ 3H]ACh from hippocampal slices. The participation of central DHP sites in the cholinergic transmission in genetic hypertension is discussed.

There are no comments yet on this publication. Be the first to share your thoughts.